Drug Shortage Report for HYDROMORPHONE HP FORTE INJECTION

Last updated on 2017-11-28 History
Report ID 2616
Drug Identification Number 02244797
Brand name HYDROMORPHONE HP FORTE INJECTION
Common or Proper name HYDROMORPHONE
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) HYDROMORPHONE HYDROCHLORIDE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 10ML
ATC code N02AA
ATC description OPIOIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-03-14
Estimated end date 2017-12-22
Actual end date 2017-11-17
Shortage status Resolved
Updated date 2017-11-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 110 RUE DE LAUZON
BOUCHERVILLE, QUEBEC
CANADA J4B 1E6
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2017-11-28 French Compare
v11 2017-11-28 English Compare
v10 2017-11-06 French Compare
v9 2017-11-06 English Compare
v8 2017-07-18 French Compare
v7 2017-07-18 English Compare
v6 2017-05-17 French Compare
v5 2017-05-17 English Compare
v4 2017-05-17 English Compare
v3 2017-03-15 English Compare
v2 2017-03-14 French Compare
v1 2017-03-14 English Compare

Showing 1 to 12 of 12